Wealth Alliance Advisory Group, LLC Cognition Therapeutics Inc Transaction History

Wealth Alliance Advisory Group, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Jan 17, 2023	SELL	$1.17 - $3.51 $5,412 - $16,237	-4,626 Reduced 25.01%	13,874 $0
Q3 2022 Oct 12, 2022	BUY	$1.67 - $3.6 $30,895 - $66,600	18,500 New	18,500 $35,000

9.4M

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $43.4M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.